GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Not yet recruitingThis early-stage trial tests a new drug called DA 3501 in people with advanced stomach or pancreatic cancers that have a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug shrinks tumors. About 51 adults will receive the drug every three we…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New triple therapy aims to wipe out HER2-positive stomach cancer before surgery
Disease control Not yet recruitingThis early-phase trial tests whether adding two targeted drugs (zanidatamab and tislelizumab) to standard chemotherapy can completely eliminate HER2-positive gastroesophageal cancer before surgery. About 29 adults with operable, locally advanced disease will receive the combinati…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 12, 2026 13:41 UTC